Malignancies in patients with insulin-treated diabetes mellitus

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 7, 2000, Pages 412-417

  Kath, Roland ^a   Schiel, Ralf ^a   Müller, Ulrich Alfons ^a   Höffken, Klaus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cancer; HbA1c; Neoplasia; Nephropathy; Peripheral neuropathy; Retinopathy; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY CARCINOMA; LONG TERM CARE; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS; POPULATION SURVEILLANCE; PREVALENCE; RISK; TIME FACTORS;

EID: 0033948525     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Abreira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS, VA CSDM Group (1995) Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Diabetes Care 18: 1113-1123
2. Alberti KGMM, Gries FA, Jervell J, Krans HMJ for the European NIDDM Policy Group (1994) A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an uptake. Diabetic Med 11: 899-909
3. American Diabetes Association (1996) Standards of medical care for patients with diabetes mellitus. Diabetes Care 19: S8-S15
4. Becker N, Wahrendorf J (eds) (1997) Atlas of cancer mortality in the Federal Republic of Germany 1981-1990. Springer Berlin Heidelberg New York
5. Berger M, Jörgens V, Flatten G (1996) Health care for patients with non-insulin-dependent diabetes mellitus. The German experience. Ann Intern Med 124: 153-155
6. Bornfeldt KE, Gidlöf RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ (1991) Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34: 307-313
7. Bruno C, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G (1998) Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study. Diabetes Med 15: 304-307
8. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN (1993a) Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 10: 313-320
9. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN (1993b) Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus. Diabetic Med 10: 305-312
10. Del Guidice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120
11. Del Prato S, Bruttomesso D (1996) Clinical aspects of beta-cell dysfunction in NIDDM. Diabetes News 17: 1-8
12. De Meyts P (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37: S135-S148
13. De Meyts P, Christoffersen CT, Ursö B, Ish-Shalom D, Sacerdoti-Sierra N, Drejer K, Schäffer L, Shymko RM, Naor D (1993) Insulin's potency as a mitogen is determined by the half-life of the insulin-receptor complex. (Abstract) Exp Clin Endocrinol 101: 22-23
14. Early Treatment Diabetic Retinopathy Study Group (1991) Ophthalmology 98 [Suppl 5]
15. European Diabetes Policy Group 1998 (1999) A desktop guide to type 1 (insulin-dependent) diabetes mellitus. Diabetic Med 16: 253-266
16. Green A, Jensen OM (1985) Frequency of cancer among insulin-treated diabetic patients in Denmark. Diabetologia 28: 128-130
17. Gullo L (1999) Diabetes and the risk of pancreatic cancer. Ann Oncol 10: S79-S81
18. Hofmann C, Goldfine ID, Whittaker J (1989) The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem 15: 8606-8611
19. Hu FB, Manson JE, Liu S, Colditz GA, Michels KB, Speizer FE, Giovannucci E (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91: 542-547
20. Janeczko D, Kopczynski J, Czyzyk A, Janeczko-Sosnowska E, Tuszynska A, Lewandowski Z (1998) Mortality of diabetic patients in Warsaw - 22 year prospective observation (1973/74-1995). II. Mortality of patients with type I diabetes (insulin-dependent). Pol Arch Med Wewn 100: 165-171
21. Kath R, Rodeck U, Parmiter A, Jambrosic J, Herlyn M (1990) Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions. Cancer Ther Control 1: 179-191
22. Kopp S, Tanneberger S, Möhner M, Kieser R (1990) Diabetes and breast cancer risk. Int J Cancer 46: 751-752
23. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107-112
24. Mendelsohn J (1995) Prinzipien der Neoplasie. In: Schmailzl K (ed) Harrisons Innere Medizin, vol 2. Blackwell Wissenschafts, Berlin pp 2123-2137
25. Nerlich AG, Hagedorn HG, Boheim M, Schleicher ED (1998) Patients with diabetes-induced microagiopathy show a reduced freuquency of carcinomas. In Vivo 12: 667-670
26. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117
27. O'Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38: 435-441
28. Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, Maina A, Chiaffarino F (1999) Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 81: 639-542
29. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Järvinen H, Evron W, Dailey G, Gerich J (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with first-degree NIDDM relative. JAMA 273: 1855-1861
30. Polonsky KS, Given BD, Hirsch LJ, Tillh H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E (1988). Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318: 1231-1239
31. Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473-486
32. Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-309
33. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW, Koprowski H (1987) Metastatic but not primary melanoma cells in vitro independently from exogenous growth factors. Int J Cancer 40: 687-690
34. Rosskamp RH, Park G (1999) Long-acting insulin analogs. Diabetes Care 22: B109-B113
35. Schiel R, Müller UA, Sprott H, Schmelzer A, Mertes B, Hunger-Dathe W, Ross IS (1997a) The JEVIN-trial: a population-based survey on the quality of diabetes care in Germany - 1994/95 compared to 1989/90. Diabetologia 40: 1350-1357
36. Schiel R, Müller UA, Sprott H, Schmelzer A, Hunger-Dathe W, Mertes B, Ross IS (1997b) Änderungen der Behandlungsqualität bei Patienten mit Typ-1-Diabetes fünf Jahre nach Verabschiedung der St. Vincent-Deklaration - Die JEVIN-Studie. Diab Stoffw 6: 239-244
37. Schiel R, Hoffmann A, Müller UA (1999) Behandlungsqualität bei Patienten mit Diabetes mellitus in einem ländlichen Gebiet Deutschlands. Ergebnisse einer Populationsuntersuchung - Die ZEUVIN - Studie. Med Klin 94: 127-132
38. Sellers TA, Andersen KE, Olson JE, Folsom AR (1998) Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer. Epidemiology 9: 102-105
39. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75: 1699-1703
40. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
41. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1194
42. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
43. Unterberger P, Sinop A, Noder W, Berger MR, Fink M, Edler L, Schmähl D, Erhart H (1990) Diabetes mellitus und Mammakarzinom. Eine retrospektive Verlaufsstudie. Onkologie 13: 17-20
44. Weiderpass E, Gridley G, Persson I, Nyrén O, Ekbom A, Adami HO (1997) Risk od endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71: 360-363
45. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365
46. Yki-Järvinen H (1995) Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388
47. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150-154